ACADIA Pharmaceuticals Inc.

ACAD

NASDAQ

Healthcare

Biotechnology

San Diego, CA, US653 employeesacadia-pharm.com

$22.18

-0.14(-0.65%)

52W $14.10 – $28.06

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders.

Revenue breakdown: Nuplazid (66.7%), Daybue (33.3%).

$3.8BMkt Cap

$1.1BRev TTM

$394MNI TTM

9.1xP/E TTM

What Changed Recently

Management Change

Mar 4, 2026

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 3, 2

Financial Results

Feb 24, 2026

have been furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or other

Financial Results

Jan 12, 2026

Results of Operations and Financial Condition. On January 13, 2026, Acadia Pharmaceuticals, Inc. (the “Company”) presented at the J.P. Morgan Healthcare Confere

Fundamentals

How The Business Makes Money

Revenue by Segment

Nuplazid66.7%($1.8B)

Daybue33.3%($917M)

Analyst View

Peer Companies

Company	Price	Change	Market Cap	P/E
BLTEBelite Bio, Inc	$169.68	+1.45%	$6.7B	-65.3
PRAXPraxis Precision Medicine...	$310.78	-2.66%	$6.6B	-21.8
IMVTImmunovant, Inc.	$24.67	-1.70%	$5.0B	-9.5
MIRMMirum Pharmaceuticals, In...	$94.24	-0.40%	$4.7B	-192.2
VKTXViking Therapeutics, Inc.	$34.87	+5.79%	$4.0B	-10.3
LGNDLigand Pharmaceuticals, I...	$199.05	-0.29%	$4.0B	31.8
CRNXCrinetics Pharmaceuticals...	$37.10	+1.46%	$3.9B	-7.0
DYNDyne Therapeutics, Inc.	$18.86	+4.20%	$3.1B	-5.1

Company Profile

CIK0001070494

ISINUS0042251084

CUSIP004225108

Phone858 558 2871

Address12830 El Camino Real, San Diego, CA, 92130, US

SEC EDGAR